{"id": "1379444487609593860", "creation": 1617720169.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted #COVID19 #Vaccine Candidate, VLA2001\n\nSeroconversion Rates (SCR) for S-protein binding IgG antibodies were 89.8% in the medium dose and 100% in the high dose group. \nhttps://t.co/NNKvTi1j5N", "first_save": 1634559108.199414, "hashtags": ["#VALNEVA", "#COVID19", "#VACCINE"]}